Navigation Links
Medarex Announces 2007 Fourth Quarter and Year End Financial Results
Date:2/26/2008

cluding the items discuss below. Medarex's management believes investors' understanding of Medarex's financial performance is enhanced as a result of our disclosing these non-GAAP financial measures. Non-GAAP net loss and non- GAAP net loss per share should not be viewed in isolation or as a substitute for GAAP net loss or GAAP net loss per share.

MEDAREX, INC.

Reconciliation of GAAP Net Loss to Non-GAAP Net Loss

(In thousands, except per share data)

(unaudited)

Year Ended Three Months Ended

December 31, December 31,

(unaudited) (unaudited)

2007 2006 2007 2006

GAAP Net loss $(27,067) $(181,701) $(44,823) $(57,705)

Celldex Net loss (1) 15,231 17,227 3,876 5,276

Minority interest -

Celldex (1) (4,699) (6,891) (157) (2,110)

Stock-based compensation

expense (2) 18,551 19,177 4,775 7,121

Acquisition of in-process

technology related

to Ability Biomedical 6,900 - - -

Impairment loss on

investments in partners 2,141 5,170 - 5,170

Non-cash gain on loss

of significant influence

in Genmab - (3,202) - -

Gain on sale of Genmab

stock (152,143) - - -

Non-GAAP Net loss $(141,086) $(150,220) $(36,329) $(42,248)

GAAP Net loss per share,

basic and diluted $(0.21) $(1.50) $(0.35) $(0.46)

Non-GAAP Net loss

per
'/>"/>

SOURCE Medarex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Medarex to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
2. Medarex to Receive Milestone Payment for Submission of Regulatory Applications Requesting Approval of Ustekinumab (CNTO 1275) for Treatment of Psoriasis
3. PharmAthene and Medarex Announce Additional $0.8 Million U.S. Government Appropriation for Continued Development of Anthrax Therapeutic Valortim(TM)
4. Medarex to Present at the JPMorgan Small/Mid Cap Conference
5. Ono and Medarex Announce Allowance of Investigational New Drug Application for Fully Human Anti-PD1 Antibody
6. Grupo Casa Saba Announces Fourth Quarter 2007 Results
7. Lixte Biotechnology Holdings, Inc. Announces Further Developments Regarding the Anti-Cancer Activity of Its Patent-Pending Proprietary Compounds
8. Reproductive Medicine Associates of Texas Announces Open House in San Antonio
9. WallSt.net (www.WallSt.net) Announces Upcoming Interview With Chairman and CEO of flexSCAN, Inc.
10. Hospira Announces New Contract With HealthTrust Purchasing Group for Infusion Devices, Solutions and Equipment
11. Thomson Healthcare Announces Enhancements to Order Sets Solution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... Phoenix, AZ and Lewisville, TX (PRWEB) May 06, 2015 ... and Adeptus Health (NYSE:ADPT) opened its first freestanding emergency ... is licensed under Dignity Health Arizona General Hospital, which ... Health joint venture. To celebrate the grand opening, Dignity ... cutting yesterday with the Chandler Chamber of Commerce and ...
(Date:5/5/2015)... May 06, 2015 It’s not your usual ... bring their classic cars and motorcycles to the 3rd Annual ... to 8 p.m. at the Lincoln VA Clinic, 600 S. ... Veterans to check out each other’s rides, but also to ... benefits and services. , Staff from the VA Nebraska-Western ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 With the FCPX ... can quickly and easily add washed color grades to footage. ... formula for modifying an image. The LUT changes every pixel's ... pack comes with 90 washed CUBE LUT files. , This ... Monochromatic can give any footage a washed look. , ...
(Date:5/5/2015)... The Journal of Pain ... Priority interventions to improve the management of chronic ... of the ACCORD program ” , As corresponding ... including clinicians, patients and family members, managers, and ... included knowledge gap, “work in silos”, lack of ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 NCPDP announced ... Partner Program. The program establishes a three-year commitment of ... maximum of 10 Elite Partners. “AmerisourceBergen has supported our ... President of NCPDP, “and this is a wonderful continuation ... , We can trace AmerisourceBergen back to our very ...
Breaking Medicine News(10 mins):Health News:Dignity Health and Adeptus Health Opened First Freestanding Emergency Room in Chandler, Arizona 2Health News:Dignity Health and Adeptus Health Opened First Freestanding Emergency Room in Chandler, Arizona 3Health News:Pixel Film Studios Announced the Release of FCPX LUT Monochromatic 2Health News:Priority interventions in chronic non-cancer pain published by Dove Medical Press 2Health News:AmerisourceBergen Joins NCPDP Elite Partner Program 2Health News:AmerisourceBergen Joins NCPDP Elite Partner Program 3
... it may be better than standard oxygen therapy, study suggests ... that a mechanical ventilator can ease suffering and help lung ... A large percentage of these patients didn,t want to have ... wear an oxygen mask. But those who were willing to ...
... in Fight Against Tobacco Recognized Nationally-, WASHINGTON, May ... the Central Regional Youth Advocate of the Year,by the ... fight,against tobacco. Michelle is being honored at a gala ... national winner, international grant winner,three other regional winners and ...
... is Possible!, DETROIT, Mich., May 19 Patrick Hendry ... of bipolar disorder.,He spent seven years in and out of ... went so far as trying,electro-convulsive therapy, similar to shock therapy., ... my life. You feel,hopeless and lost," said Hendry. "It,s difficult ...
... WASHINGTON, May 20 Auriel Rolle-Polk, 17, of,Tallahassee, FL ... the,Year by the Campaign for Tobacco-Free Kids for her ... at a gala in the nation,s capital,on May 20 ... regional winners and a group winner., Auriel, a ...
... 20 Caraco Pharmaceutical,Laboratories, Ltd. (Amex: CPD ... its fourth quarter and fiscal year 2008 ended ... Thursday May 29, 2008., Detroit-based Caraco Pharmaceutical ... private-label,pharmaceuticals to the nation,s largest wholesalers, distributors,drugstore chains ...
... Ischemic injury to the bowel is a well known disease ... findings. A sudden drop in the colonic blood supply is ... of macrovascular mesenteric vein rarely causes ischemia of the bowel. ... by obstruction of the mesenteric and splenic veins. , ...
Cached Medicine News:Health News:Ventilator Relieves Lung Cancer Pain in Final Hours 2Health News:Ventilator Relieves Lung Cancer Pain in Final Hours 3Health News:Campaign for Tobacco-Free Kids Honors Michelle Mays of Rhinelander, WI As Youth Advocate of the Year 2Health News:Man who Lost Everything Comes to Detroit to Spread Message of Hope 2Health News:Campaign for Tobacco-Free Kids Honors Auriel Rolle-Polk of Tallahassee, FL As Youth Advocate of the Year 2Health News:Caraco Pharmaceutical Laboratories, Ltd. to Announce Fourth Quarter and Fiscal Year 2008 Results on May 29, 2008 2
(Date:5/5/2015)... May 5, 2015  Trovagene, Inc. (NASDAQ:  TROV), ... its financial results for the three months ended ... first quarter, we presented favorable clinical results at ... Conference, demonstrating our Precision Cancer Monitoring platform,s ability ... colorectal, and lung cancers," said Antonius Schuh, Ph.D., ...
(Date:5/5/2015)... -- IBM Watson Health (NYSE: IBM ) today announced ... leading cancer institutes to accelerate the ability of clinicians ... The institutes will apply Watson,s ... the ability to translate DNA insights, understand a person,s ... to personalize treatment options. The project is part of ...
(Date:5/5/2015)... WORTH, Texas , May 5, 2015 ... was valued at $94.9 million in 2014, and is ... a CAGR of 7.8% from 2014 to 2019. ... Glaucoma Surgery Device Market for an analysis of industry ... and figures. http://www.micromarketmonitor.com/market/north-america-glaucoma-surgery-devices-8830146604.html ...
Breaking Medicine Technology:Trovagene, Inc. Announces First Quarter 2015 Financial Results 2Trovagene, Inc. Announces First Quarter 2015 Financial Results 3Trovagene, Inc. Announces First Quarter 2015 Financial Results 4Trovagene, Inc. Announces First Quarter 2015 Financial Results 5Trovagene, Inc. Announces First Quarter 2015 Financial Results 6Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 2Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 3Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 4Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 5Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 6North America Ophthalmology Glaucoma Surgery Device Market is Expected to Reach $138.3 Million by 2019, at a CAGR of 7.8% From 2014 to 2019 2North America Ophthalmology Glaucoma Surgery Device Market is Expected to Reach $138.3 Million by 2019, at a CAGR of 7.8% From 2014 to 2019 3
... Inc. (Nasdaq: ANTH ), a biopharmaceutical company ... autoimmune disorders, today announced that it has appointed Dr. ... "Bogdan,s extensive global regulatory expertise and broad industry ... continue to navigate the evolving FDA regulatory landscape," said ...
... CLARK, N.J., March 5, 2012  Kerri Eckroat, RN, BSN, ... member of SurroundHealth , a free online community ... Eckroat said: "I believe that educating myself is crucial ... patients deserve the best. By learning from other healthcare ...
Cached Medicine Technology:Dr. Bogdan Dziurzynski Joins Anthera Pharmaceuticals Board of Directors 2Dr. Bogdan Dziurzynski Joins Anthera Pharmaceuticals Board of Directors 3SurroundHealth Online Community Reaches 1,000 Members 2SurroundHealth Online Community Reaches 1,000 Members 3
... system device is comprised of the following ... creating each access port are also packaged ... insufflation and access needle, 14 gauge, 100 ... radially expandable sleeve, 100 mm length is ...
BLUNTPORT Plus Single Use Converterless 5 mm - 12 mm Trocar System for Open Laparoscopy....
... Auto Suture™ VERSAPORT™ PLUS V2 RT single-use obturator ... locking shield. , ,The Auto Suture™ VERSAPORT™ ... 5 -11, 5-12, 11 mm and 12 mm ... 5 mm and 5 mm short single-use obturators ...
... mm and VersaStep™ PLUS Reposable system components for creating ... The radial expandable sleeve is packaged sterile together with ... Insufflation and access needle is packaged non-sterile; ... dilators are packaged non-sterile; 5 mm, 7/8 mm, ...
Medicine Products: